| Şartname | Detay / Değer |
| Ürün Adı | Atlas Koroner Stent (Kobalt Krom) |
| Stent Tipi | Balonla Genişletilebilen Koroner Stent |
| Malzeme | Kobalt-Krom Alaşımı |
| Destek Kalınlığı | ~80 µm (tipik) |
| Tasarım | Açık hücreli veya hibrit hücreli mimari (tam modele bağlı olarak) |
| Nominal Basınç (NP) | 9–10 atm |
| Nominal Patlama Basıncı (RBP) | ~14–16 atm |
| Stent Dağıtım Sistemi | Hızlı Değişim (RX) veya Kablo Üzerinden (OTW), genellikle 140 cm şaft uzunluğu |
| Kılavuz Tel Uyumluluğu | 0,014” |
| Stent Yüzeyi | Çıplak metal veya isteğe bağlı ilaç salan polimer (eğer varsa) |
| Endikasyonlar | Koroner arter lezyon iskelesi, tek veya çok damar hastalığı, küçük/orta/büyük damarlarda potansiyel kullanım |
| Kontrendikasyonlar | Balonla genişletilebilen stent tedavisi için uygun olmayan lezyonlar (örneğin, ciddi şekilde kalsifiye olmuş, sol ana gövde, vb.) veya doktorun takdirine bağlı olarak |
| Kısırlık | Steril (Etilen Oksit) |
| Tek Kullanımlık | Evet |
| Raf ömrü | 2–3 yıl (son ambalaja ve varsa polimere bağlı olarak) |
| Çalışma Sıcaklığı | Depolama için önerilen sıcaklık 15–25 °C |
Ayrıntılı Beden Bazlı Sipariş ve Ürün Kodları
| Stent Çapı (mm) | Stent Uzunluğu (mm) | Nominal Basınç (atm) | RBP (atm) | Ürün Kodu |
| 2.00 | 8 | 9 | 14 | ATLS-CC-2.00x08 |
| 2.00 | 12 | 9 | 14 | ATLS-CC-2.00x12 |
| 2.00 | 15 | 9 | 14 | ATLS-CC-2.00x15 |
| 2.00 | 18 | 10 | 16 | ATLS-CC-2.00x18 |
| 2.00 | 24 | 10 | 16 | ATLS-CC-2.00x24 |
| 2.00 | 28 | 10 | 16 | ATLS-CC-2.00x28 |
| 2.00 | 32 | 10 | 16 | ATLS-CC-2.00x32 |
| 2.00 | 38 | 10 | 16 | ATLS-CC-2.00x38 |
| 2.25 | 8 | 9 | 14 | ATLS-CC-2.25x08 |
| 2.25 | 12 | 9 | 14 | ATLS-CC-2.25x12 |
| 2.25 | 15 | 9 | 14 | ATLS-CC-2.25x15 |
| 2.25 | 18 | 10 | 16 | ATLS-CC-2.25x18 |
| 2.25 | 24 | 10 | 16 | ATLS-CC-2.25x24 |
| 2.25 | 28 | 10 | 16 | ATLS-CC-2.25x28 |
| 2.25 | 32 | 10 | 16 | ATLS-CC-2.25x32 |
| 2.25 | 38 | 10 | 16 | ATLS-CC-2.25x38 |
| 2.50 | 8 | 9 | 14 | ATLS-CC-2.50x08 |
| 2.50 | 12 | 9 | 14 | ATLS-CC-2.50x12 |
| 2.50 | 15 | 9 | 14 | ATLS-CC-2.50x15 |
| 2.50 | 18 | 10 | 16 | ATLS-CC-2.50x18 |
| 2.50 | 24 | 10 | 16 | ATLS-CC-2.50x24 |
| 2.50 | 28 | 10 | 16 | ATLS-CC-2.50x28 |
| 2.50 | 32 | 10 | 16 | ATLS-CC-2.50x32 |
| 2.50 | 38 | 10 | 16 | ATLS-CC-2.50x38 |
| 2,75 | 8 | 9 | 14 | ATLS-CC-2.75x08 |
| 2,75 | 12 | 9 | 14 | ATLS-CC-2.75x12 |
| 2,75 | 15 | 9 | 14 | ATLS-CC-2.75x15 |
| 2,75 | 18 | 10 | 16 | ATLS-CC-2.75x18 |
| 2,75 | 24 | 10 | 16 | ATLS-CC-2.75x24 |
| 2,75 | 28 | 10 | 16 | ATLS-CC-2.75x28 |
| 2,75 | 32 | 10 | 16 | ATLS-CC-2.75x32 |
| 2,75 | 38 | 10 | 16 | ATLS-CC-2.75x38 |
| 3.00 | 8 | 9 | 14 | ATLS-CC-3.00x08 |
| 3.00 | 12 | 9 | 14 | ATLS-CC-3.00x12 |
| 3.00 | 15 | 9 | 14 | ATLS-CC-3.00x15 |
| 3.00 | 18 | 10 | 16 | ATLS-CC-3.00x18 |
| 3.00 | 24 | 10 | 16 | ATLS-CC-3.00x24 |
| 3.00 | 28 | 10 | 16 | ATLS-CC-3.00x28 |
| 3.00 | 32 | 10 | 16 | ATLS-CC-3.00x32 |
| 3.00 | 38 | 10 | 16 | ATLS-CC-3.00x38 |
| 3.25 | 12 | 9 | 14 | ATLS-CC-3.25x12 |
| 3.25 | 15 | 9 | 14 | ATLS-CC-3.25x15 |
| 3.25 | 18 | 10 | 16 | ATLS-CC-3.25x18 |
| 3.25 | 24 | 10 | 16 | ATLS-CC-3.25x24 |
| 3.25 | 28 | 10 | 16 | ATLS-CC-3.25x28 |
| 3.25 | 32 | 10 | 16 | ATLS-CC-3.25x32 |
| 3.25 | 38 | 10 | 16 | ATLS-CC-3.25x38 |
| 3.50 | 8 | 9 | 14 | ATLS-CC-3.50x08 |
| 3.50 | 12 | 9 | 14 | ATLS-CC-3.50x12 |
| 3.50 | 15 | 9 | 14 | ATLS-CC-3.50x15 |
| 3.50 | 18 | 10 | 16 | ATLS-CC-3.50x18 |
| 3.50 | 24 | 10 | 16 | ATLS-CC-3.50x24 |
| 3.50 | 28 | 10 | 16 | ATLS-CC-3.50x28 |
| 3.50 | 32 | 10 | 16 | ATLS-CC-3.50x32 |
| 3.50 | 38 | 10 | 16 | ATLS-CC-3.50x38 |
| 4.00 | 8 | 9 | 14 | ATLS-CC-4.00x08 |
| 4.00 | 12 | 9 | 14 | ATLS-CC-4.00x12 |
| 4.00 | 15 | 9 | 14 | ATLS-CC-4.00x15 |
| 4.00 | 18 | 10 | 16 | ATLS-CC-4.00x18 |
| 4.00 | 24 | 10 | 16 | ATLS-CC-4.00x24 |
| 4.00 | 28 | 10 | 16 | ATLS-CC-4.00x28 |
| 4.00 | 32 | 10 | 16 | ATLS-CC-4.00x32 |
| 4.00 | 38 | 10 | 16 | ATLS-CC-4.00x38 |
The ATLAS Drug Eluting Coronary Stent System is a next-generation cobalt-chromium (CoCr) stent platform coated with a sirolimus formulation (1 µg/mm²) designed to reduce restenosis in patients with coronary artery disease. By combining advanced laser-cutting technology and a clinically proven antiproliferative drug, the ATLAS system delivers durable vessel patency and a high safety profile in both de novo lesions and in-stent restenosis scenarios.
Cobalt-Chromium Alloy (L605) Construction
•Ensures exceptional strength-to-thickness ratio, enabling thinner struts without compromising radial force.
•Exhibits excellent corrosion resistance and biocompatibility for a stable healing environment.
Laser-Cut Stent Design
•Precision machining yields consistent strut geometry, promoting uniform drug distribution and an even healing surface along the vessel wall.
•Enhances stent deliverability, allowing smooth passage through calcified or tortuous coronary segments.
Sirolimus Elution Profile
•1 µg/mm² of sirolimus is coated onto the stent’s surface, ensuring a sustained, controlled release that minimizes in-stent neointimal growth.
•Controlled drug release aids in rapid endothelialization, lowering the risk of late stent thrombosis.
Radiopaque Pt-Ir Markers
•Platinum-iridium markers at stent edges enable precise visibility under fluoroscopy.
•Facilitates accurate positioning during percutaneous coronary intervention (PCI) procedures.
High-Pressure Capability
interventional cardiologists flexibility to optimize stent expansion based on lesion complexity.
